Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Minghetti

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|September 10, 2021
The Antihypertensive Drug Telmisartan Protects Oligodendrocytes from Cholesterol Accumulation and Promotes Differentiation by a PPAR-γ-Mediated MechanismAntonietta Bernardo, Mariagiovanna Malara, Lucia Bertuccini, et al.
Neurochemical Research|May 14, 2004
Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functionsLuisa Minghetti, Sergio Visentin, Mario Patrizio, et al.
Journal of the Neurological Sciences|September 29, 2004
Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosisAnita Greco, Luisa Minghetti, Maria Puopolo, et al.
Clinical Biochemistry|October 24, 2007
Plasma levels of 15-F(2t)-isoprostane in newborn infants are affected by mode of deliveryAnita Greco, Luisa Minghetti, Maria Puopolo, et al.
Critical Reviews in Neurobiology|December 8, 2004
Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadowsPatrizia Popoli, Luisa Minghetti, Maria Teresa Tebano, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegenerationLuisa Minghetti, Anita Greco, Rosa Luisa Potenza, et al.
International Journal of Molecular Sciences|August 27, 2021
Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic PerspectivesAntonietta Bernardo, Chiara De Nuccio, Sergio Visentin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 27, 2013
The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patientsSergio Visentin, Chiara De Nuccio, Antonietta Bernardo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 27, 2016
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral SclerosisRosa Luisa Potenza, Roberta De Simone, Monica Armida, et al.
Experimental Neurology|October 30, 2007
Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxiaPaola Piscopo, Antonietta Bernardo, Gemma Calamandrei, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|September 10, 2021
The Antihypertensive Drug Telmisartan Protects Oligodendrocytes from Cholesterol Accumulation and Promotes Differentiation by a PPAR-γ-Mediated MechanismAntonietta Bernardo, Mariagiovanna Malara, Lucia Bertuccini, et al.
Neurochemical Research|May 14, 2004
Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functionsLuisa Minghetti, Sergio Visentin, Mario Patrizio, et al.
Journal of the Neurological Sciences|September 29, 2004
Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosisAnita Greco, Luisa Minghetti, Maria Puopolo, et al.
Clinical Biochemistry|October 24, 2007
Plasma levels of 15-F(2t)-isoprostane in newborn infants are affected by mode of deliveryAnita Greco, Luisa Minghetti, Maria Puopolo, et al.
Critical Reviews in Neurobiology|December 8, 2004
Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadowsPatrizia Popoli, Luisa Minghetti, Maria Teresa Tebano, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegenerationLuisa Minghetti, Anita Greco, Rosa Luisa Potenza, et al.
International Journal of Molecular Sciences|August 27, 2021
Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic PerspectivesAntonietta Bernardo, Chiara De Nuccio, Sergio Visentin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 27, 2013
The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patientsSergio Visentin, Chiara De Nuccio, Antonietta Bernardo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 27, 2016
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral SclerosisRosa Luisa Potenza, Roberta De Simone, Monica Armida, et al.
Experimental Neurology|October 30, 2007
Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxiaPaola Piscopo, Antonietta Bernardo, Gemma Calamandrei, et al.
Pageof 9